According to the settlement agreement, MD Labs and its owners, Denis Grizelj and Matthew Rutledge, admit that they regularly billed federal health care programs for medically unnecessary presumptive and confirmatory urine drug testing between 2015 and 2019.
The lab allegedly performed both types of tests at approximately the same time, then simultaneously submitted the results of each to health care providers.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.